Back to search
FDAFDA · Food and drugs·Recall number Z-1020-2024

BD BBL Sensi Disc Cefotaxime - 30 ug®, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607®; 5 ug, Catalog No. 291308®

Published February 14, 2024 · Recall initiated: January 8, 2024

Summary

FDA records medical device Class II recall Z-1020-2024, published February 14, 2024 and initiated January 8, 2024. Recalling firm: Becton Dickinson & Co.; Status: Ongoing; Reported quantity: 2,363,168 total units; Lot: Catalog No. 231606 UDI-DI 00382902316060 Lots 2004580 2025164 2090467 2146516 2180432 2301360 3003886; Catalog No. 231607 UDI-DI 30382902316078 Lots 2301360 3062270 3158078 3261093 2004580 2025164 2090467 2146516 2180432 3003886; Catalog No. 291308® UDI-DI N/A Lots 2301468 3003046 3093596 3116037 3248537 3248540. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Co.
Distributor
Domestic distribution nationwide. International distribution worldwide.
Lot
Catalog No. 231606 UDI-DI 00382902316060 Lots 2004580 2025164 2090467 2146516 2180432 2301360 3003886; Catalog No. 231607 UDI-DI 30382902316078 Lots 2301360 3062270 3158078 3261093 2004580 2025164 2090467 2146516 2180432 3003886; Catalog No. 291308® UDI-DI N/A Lots 2301468 3003046 3093596 3116037 3248537 3248540
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BD BBL Sensi Disc Cefotaxime - 30 ug®, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607®; 5 ug, Catalog No. 291308® recalled?

Yes. FDA published recall Z-1020-2024 on February 14, 2024. Reported hazard: There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

What should I do if I have this product?

Voluntary: Firm initiated · Letter